| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/24/1991 | EP0424051A1 Glycopeptide antibiotics |
| 04/24/1991 | EP0423869A1 Infectious bronchitis virus vaccine |
| 04/24/1991 | EP0423695A2 Aerosol composition for topical medicament |
| 04/24/1991 | EP0423649A1 Peptides and use thereof |
| 04/24/1991 | EP0423191A1 Treatment of genital warts with a combination of podophyllin and recombinant dna human alpha interferon |
| 04/24/1991 | CA2028209A1 Quinolone compounds and a process for their preparation |
| 04/24/1991 | CA2028208A1 Quinolone compounds and a process for their preparation |
| 04/24/1991 | CA2028176A1 Carbapenem compounds |
| 04/23/1991 | US5010060 Method of treating herpes simplex viral infection employing pyrimidine derivatives |
| 04/23/1991 | CA1283416C Carbamoyloxymethylalkylcarbapenem compounds |
| 04/23/1991 | CA1283361C Antiviral combinations |
| 04/21/1991 | WO1991005546A1 Solid tumor treatment method and composition |
| 04/21/1991 | WO1991005545A1 Liposome microreservoir composition and method |
| 04/21/1991 | CA2028045A1 Infectious bronchitis virus vaccine |
| 04/20/1991 | CA2027952A1 Topical medicinal pressurized aerosol compositions and method of preparation, method of use and article of manufacture thereof |
| 04/18/1991 | WO1991005552A1 Method and compositions for inhibition of disorders associated with oxidative damage |
| 04/18/1991 | WO1991004985A1 Dehydrodidemnin b |
| 04/18/1991 | WO1991004972A1 1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents |
| 04/18/1991 | WO1991004750A1 Method of treatment |
| 04/18/1991 | WO1991004749A1 Method of treating infectious bursal disease virus |
| 04/18/1991 | WO1991002805A3 Recombinant retroviruses delivering vector constructs to target cells |
| 04/18/1991 | WO1990015066A3 Nucleotidic sequences resulting from the retrovirus gemone of the hiv-1, hiv-2, and siv type, and their applications, in particular for the amplification of the genomes of said retroviruses and for the in vitro diagnosis of infections caused by these viruses |
| 04/18/1991 | DE3934366A1 Vakzine zum schutz vor hiv-virusinfektionen, verfahren zu ihrer herstellung und ihre verwendung als diagnostikum und immuntherapeutikum Vaccine to protect against hiv virus infections, methods for their production and their use as diagnostic and immunotherapeutic |
| 04/17/1991 | WO1991005860A1 Non-infectious hiv-1 particles and uses therefor |
| 04/17/1991 | EP0422843A2 6-0 Methylerythromycin A oxime derivatives |
| 04/17/1991 | EP0422596A2 Tricyclic carbapenem compounds |
| 04/17/1991 | EP0422485A2 Quinolone carboxylic acid derivatives, process for their preparation and their use |
| 04/17/1991 | EP0422215A1 Antibacterial and antimalarial peptides |
| 04/17/1991 | EP0422097A1 Method of inhibiting the activity of human immunodeficiency virus (hiv) in vivo. |
| 04/17/1991 | CN1050717A Cephalosporin derivatives |
| 04/17/1991 | CA2067778A1 Non-infectious hiv-1 particles and uses therefor |
| 04/17/1991 | CA2027637A1 N-acetylmuramidase m1 |
| 04/16/1991 | US5008384 Process for the production of O.sup. 2,2'-anhydro-1-(β-D-arabinofuranosyl)thymine |
| 04/16/1991 | US5008371 Biologically active polypeptide and use thereof |
| 04/16/1991 | US5008259 Antibiotics active against strains of Pseudomonas and stable to beta-lactamase |
| 04/16/1991 | US5008258 Cephalosporin derivatives |
| 04/16/1991 | US5008250 Parasiticides |
| 04/16/1991 | CA1283118C Hydroxypyrazole derivatives, their preparation and their use against microorganisms |
| 04/16/1991 | CA1283096C Antibacterial compounds |
| 04/14/1991 | WO1991005754A2 Derivatives of long-chain fatty alcohols and their applications, in particular as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing same |
| 04/14/1991 | CA2044162A1 Long-chained fatty alcohol derivatives, their applications, specifically as cytotrphic and cytoprotecting molecules, and pharmaceutical compounds containing same |
| 04/13/1991 | CA2027455A1 Hiv related peptides |
| 04/13/1991 | CA2027204A1 Quinolonecarboxylic acid derivatives, process for their preparation and their use as antiviral agents |
| 04/12/1991 | CA2027237A1 Tricyclic carbapenem compounds |
| 04/11/1991 | DE4029747A1 Psoriasis treatment |
| 04/11/1991 | CA2027126A1 Compositions and methods for treating or preventing infections in canine and feline animals |
| 04/10/1991 | EP0421777A1 Further antiviral pyrimidine nucleosides |
| 04/10/1991 | EP0421752A2 Substituted acrylamido-penicillanic acid derivatives |
| 04/10/1991 | EP0421751A2 Substituted acrylamido-penicillanic acid esters |
| 04/10/1991 | EP0421739A1 3'-azido purine nucleoside |
| 04/10/1991 | EP0421733A2 Amphotericin B lipid complex |
| 04/10/1991 | EP0421668A2 1,4-Dihydro-4-oxo-3-quinolone derivatives as selectively toxic mammalian antibacterial agents |
| 04/10/1991 | EP0421635A1 Chimaeric hepadnavirus core antigen proteins |
| 04/10/1991 | EP0421382A1 Monoclonal antibody to exotoxin A of pseudomonas aeruginosa |
| 04/10/1991 | EP0421210A2 Triazole compounds, their production and use |
| 04/10/1991 | EP0421074A1 Pharmacologically active peptides and pharmaceutical preparations containing them |
| 04/10/1991 | EP0420849A1 Use of sucralfate |
| 04/10/1991 | CN1050545A Inhibitor of retroinfection viral protease |
| 04/10/1991 | CN1050503A Stabilized leukocyte-interferons |
| 04/09/1991 | US5006337 For treating skin disorders |
| 04/09/1991 | CA1282783C Substituted dihydroimidazo ¬1,2-a| quinoxalines |
| 04/09/1991 | CA1282780C Alkyl-substituted benzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the same |
| 04/09/1991 | CA1282779C Polysaccharide ron substance, production of the same and use of the same |
| 04/09/1991 | CA1282722C Antibiotic tan-749, production and use thereof |
| 04/09/1991 | CA1282721C Herpes simplex virus as a vector |
| 04/08/1991 | CA2027074A1 6-0-methylerythromycin a oxime derivatives |
| 04/07/1991 | WO1991005536A2 Novel oxidized lipoproteins and methods for their preparation |
| 04/07/1991 | WO1991004744A1 Methods and apparatus for treating disease states using oxidized lipoproteins |
| 04/07/1991 | CA2067364A1 Oxidized lipoproteins and methods for their preparation |
| 04/07/1991 | CA2067356A1 Methods for treating diseases using oxidized lipoproteins |
| 04/07/1991 | CA2026972A1 1,4-dihydro-4-oxo-3-quinolone derivatives as selectively toxic mammalian antibacterial agents |
| 04/06/1991 | CA2026786A1 Compounds |
| 04/05/1991 | WO1991004982A1 Further antiviral pyrimidine nucleosides |
| 04/05/1991 | CA2067094A1 Further antiviral pyrimidine nucleosides |
| 04/05/1991 | CA2026803A1 Monoclonal antibody to exotoxin a of pseudomonas aeruginosa |
| 04/04/1991 | WO1991004319A1 Therapeutic ribozyme compositions and expression vectors |
| 04/04/1991 | WO1991004261A1 5'-alkylphosphonylnucleosides as antivirals |
| 04/04/1991 | WO1991004049A1 CONJUGATE VACCINE FOR GROUP B $i(STREPTOCOCCUS) |
| 04/04/1991 | WO1991004033A1 2'-deoxy-4'-thioribonucleosides as antiviral and anticancer agents |
| 04/04/1991 | CA2383393A1 Conjugate vaccine for group b streptococcus |
| 04/04/1991 | CA2066684A1 Therapeutic ribozyme compositions and expression vectors |
| 04/04/1991 | CA2026730A1 Therapeutic nucleosides |
| 04/04/1991 | CA2012101A1 Antiviral medicinal composition |
| 04/03/1991 | EP0420798A1 Antimicrobial compositions |
| 04/03/1991 | EP0420543A2 Cephalosporin compounds |
| 04/03/1991 | EP0420116A2 Novel substituted alkyl piperidines and their use as inhibitors of cholesterol synthesis |
| 04/03/1991 | EP0420069A2 Heterocyclic hydrazide derivatives of monocyclic beta-lactam antibiotics |
| 04/03/1991 | EP0420049A1 Stabilized leucocyte-interferon |
| 04/03/1991 | EP0419998A2 Use of alkylphosphonic acid derivatives for the treatment of psoriasis |
| 04/03/1991 | EP0419861A2 Use of dibenz[b,f][1,4]oxazepin (and thiazepin)-11(10H)-ones and -thiones in the preparation of a pharmaceutical composition for the prevention or treatment of aids |
| 04/03/1991 | EP0419576A1 Enterically transmitted non-a/non-b hepatitis viral agent |
| 04/03/1991 | EP0419501A1 Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinaceous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components. |
| 04/03/1991 | CN1050380A Substituted alkyl piperidines and their use as inhibitors of cholesterol synthesis |
| 04/03/1991 | CN1050320A Pulsatile once-a-day delivery systems for aminotetra cycline |
| 04/03/1991 | CA2024781A1 Method for treating systemic candida infections with a single dose administration of amphotericin b lipid complex |
| 04/02/1991 | US5004747 Isoquinolinones |
| 04/02/1991 | US5004746 Anti-retroviral castanospermine esters |
| 04/02/1991 | US5004745 Bactericides |
| 04/02/1991 | US5004738 For treating bacterial infections in mammals |
| 04/02/1991 | US5004735 Pharmaceutical compositions for the inhibition of tumor metastasis |